Technical Analysis for BSTC - BioSpecifics Technologies Corp

Grade Last Price % Change Price Change
grade F 57.75 -1.21% -0.71
BSTC closed down 1.21 percent on Friday, September 20, 2019, on 1.31 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Up
See historical BSTC trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
50 DMA Support Bullish -1.21%
Stochastic Sell Signal Bearish -1.15%
Crossed Above 50 DMA Bullish -1.15%
MACD Bullish Centerline Cross Bullish -1.15%
Narrow Range Bar Range Contraction -1.15%
NR7 Range Contraction -1.15%

Older signals for BSTC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase for various clinical indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of adult Dupuytren's contracture patients with a palpable cord. The company also develops XIAFLEX injectable collagenase for Peyronie's disease, frozen shoulder, cellulite, human lipoma, and canine lipoma indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. to develop, market, and sell injectable collagenase. The company was founded in 1957 and is headquartered in Lynbrook, New York.
Biopharmaceutical Organ Systems Glaucoma Anatomy Cosmetic Surgery Cellulite Keloid Keloids
Is BSTC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 73.31
52 Week Low 52.03
Average Volume 51,637
200-Day Moving Average 62.3079
50-Day Moving Average 58.018
20-Day Moving Average 56.2375
10-Day Moving Average 57.335
Average True Range 1.7776
ADX 16.88
+DI 18.5715
-DI 20.1134
Chandelier Exit (Long, 3 ATRs ) 53.9009
Chandelier Exit (Short, 3 ATRs ) 57.3628
Upper Bollinger Band 59.5115
Lower Bollinger Band 52.9635
Percent B (%b) 0.73
BandWidth 11.643476
MACD Line 0.1675
MACD Signal Line -0.2737
MACD Histogram 0.4412
Fundamentals Value
Market Cap 413.72 Million
Num Shares 7.16 Million
EPS 1.63
Price-to-Earnings (P/E) Ratio 35.43
Price-to-Sales 11.74
Price-to-Book 5.25
PEG Ratio 1.30
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.70
Resistance 3 (R3) 59.92 59.48 59.38
Resistance 2 (R2) 59.48 58.99 59.38 59.27
Resistance 1 (R1) 58.62 58.68 58.40 58.40 59.16
Pivot Point 58.18 58.18 58.08 58.08 58.18
Support 1 (S1) 57.32 57.69 57.10 57.10 56.34
Support 2 (S2) 56.88 57.38 56.78 56.23
Support 3 (S3) 56.02 56.88 56.13
Support 4 (S4) 55.80